ICICI Bank Limited
NYSE:IBNBanks - Regional
+$0.14 today
- Market cap
- $125.27B
- Beta
- 0.25
- P/E (TTM)
- 17.7
- EPS (TTM)
- $75.75
- Dividend yield
- 0.82%
Volume 6.97M
Average 7.14M
IBN Weighted Avg Shares
Average number of basic shares outstanding during the period, used to calculate basic EPS.
ICICI Bank LimitedNYSE: IBN
Weighted Avg Shares · Q2 FY2027 · quarter ended Sep 2026
Weighted avg shares grows in line with its trailing trend
Q2 FY2027 weighted avg shares of 3.59B shares rose 0.7% year over year, in line with the +0.4% change in trailing-twelve-month weighted avg shares. Sequentially, it rose 0.1% from the prior quarter. Over 3 fiscal years it compounded at +0.8% a year.
Context
- Weighted avg shares increased in 2 of the last 3 fiscal years.
What to watch
Whether quarterly growth of +0.7% holds above the trailing-twelve-month pace of +0.4%.
Sources:Income StatementText generated from reported figures; not investment advice.
Weighted Avg Shares history
Shares · from the income statement
- Latest · FY2026
- 3.57B INR
- Year-over-year change
- -0.4%
- 4-year CAGR
- +0.7%
| Period | Period end | Weighted Avg Shares | YoY change |
|---|---|---|---|
| FY2026 | 2026-03-31 | 3.57B | -0.4% |
| FY2025 | 2025-03-31 | 3.59B | +2.4% |
| FY2024 | 2024-03-31 | 3.5B | +0.5% |
| FY2023 | 2023-03-31 | 3.48B | +0.5% |
| FY2022 | 2022-03-31 | 3.47B | — |
Weighted Avg Shares vs competitors
How IBN compares with its peers on the latest reported figures
- IBN's LTM Sep 2026 weighted avg shares of 3.58B shares is the lowest of the 2 companies compared; the peer median is 5.14B shares.
- Its year-over-year change of +0.4% is the highest of 2, against a peer median of +0.4%.
- Over three fiscal years its annual growth of +0.8% compares with a peer median of +11.3%.
| Company | Period | LTM | YoY | 3-year CAGR |
|---|---|---|---|---|
| LTM Sep 2026 | 5.14B | +0.4% | +11.3% | |
| LTM Sep 2026 | 3.58B | +0.4% | +0.8% | |
| Peer median (excluding IBN) | 5.14B | +0.4% | +11.3% | |
Competitors are the stored peer set for IBN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2022 Mar 2022 | FY2023 Mar 2023 | FY2024 Mar 2024 | FY2025 Mar 2025 | FY2026 Mar 2026 |
|---|---|---|---|---|---|
| Revenue | 1.58T | 1.85T | 2.35T | 2.95T | 3.12T |
| Cost of Revenue | 586.01B | 560.92B | 750.72B | 939.33B | 946.67B |
| Gross Profit | 989.3B | 1.29T | 1.6T | 2.01T | 2.17T |
| Gross Margin | 62.8% | 69.6% | 68.1% | 68.1% | 69.7% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 258.7B | 301.95B | 370.33B | 236.3B | 1.07T |
| Operating Expenses | 723.92B | 813.86B | 987.38B | 1.28T | 1.4T |
| Depreciation & Amortization | 14.7B | 16.35B | 19.96B | 26.9B | 31.23B |
| EBITDA | 280.08B | 488.9B | 635.04B | 1.65T | 804.43B |
| EBITDA Margin | 17.8% | 26.5% | 27.0% | 55.9% | 25.8% |
| Operating Income | 265.38B | 472.55B | 615.08B | 730.04B | 773.2B |
| Operating Margin | 16.8% | 25.6% | 26.1% | 24.8% | 24.8% |
| Interest Income | 954.07B | 1.21T | 1.6T | 1.86T | 1.95T |
| Interest Expense | 411.67B | 505.43B | 741.08B | 890.27B | 890.29B |
| Other Income / Expenses | 0 | 0 | 0 | 0 | 0 |
| Income Before Tax | 265.38B | 472.55B | 615.08B | 730.04B | 773.2B |
| Pre-Tax Margin | 16.8% | 25.6% | 26.1% | 24.8% | 24.8% |
| Income Tax Expense | 0 | 117.93B | 154.28B | 184.35B | 193.84B |
| Net Income | 251.1B | 340.37B | 442.56B | 510.29B | 542.08B |
| Net Margin | 15.9% | 18.4% | 18.8% | 17.3% | 17.4% |
| EPS (Basic) | 72.42 | 97.72 | 126.38 | 144.82 | 151.78 |
| EPS (Diluted) | 70.98 | 95.82 | 124.10 | 142.28 | 149.54 |
| Weighted Avg Shares | 3.47B | 3.48B | 3.5B | 3.59B | 3.57B |
| Weighted Avg Shares (Diluted) | 3.54B | 3.55B | 3.57B | 3.59B | 3.62B |
ICICI Bank Limited
NYSE:IBN
Intrinsic Alpha fair value
Locked
Current Price
$34.89
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.